DE69836976D1 - Neospora impstoff - Google Patents

Neospora impstoff

Info

Publication number
DE69836976D1
DE69836976D1 DE69836976T DE69836976T DE69836976D1 DE 69836976 D1 DE69836976 D1 DE 69836976D1 DE 69836976 T DE69836976 T DE 69836976T DE 69836976 T DE69836976 T DE 69836976T DE 69836976 D1 DE69836976 D1 DE 69836976D1
Authority
DE
Germany
Prior art keywords
neospora
vaccines
tachyzoites
impstoff
caninum
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69836976T
Other languages
English (en)
Other versions
DE69836976T2 (de
Inventor
Leszek Choromanski
K Brown
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer Corp
Original Assignee
Bayer Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Corp filed Critical Bayer Corp
Application granted granted Critical
Publication of DE69836976D1 publication Critical patent/DE69836976D1/de
Publication of DE69836976T2 publication Critical patent/DE69836976T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/002—Protozoa antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/10—Protozoa; Culture media therefor
    • C12N1/105—Protozoal isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/90—Protozoa ; Processes using protozoa

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Microbiology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Zoology (AREA)
  • Public Health (AREA)
  • Biotechnology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE69836976T 1997-10-20 1998-10-13 Neospora impstoff Expired - Fee Related DE69836976T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US95453197A 1997-10-20 1997-10-20
US954531 1997-10-20
PCT/US1998/021515 WO1999020303A1 (en) 1997-10-20 1998-10-13 Neospora vaccines

Publications (2)

Publication Number Publication Date
DE69836976D1 true DE69836976D1 (de) 2007-03-15
DE69836976T2 DE69836976T2 (de) 2007-11-08

Family

ID=25495565

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69836976T Expired - Fee Related DE69836976T2 (de) 1997-10-20 1998-10-13 Neospora impstoff

Country Status (12)

Country Link
US (2) US20020146436A1 (de)
EP (1) EP1032416B1 (de)
JP (1) JP2001520205A (de)
KR (1) KR20010024245A (de)
AT (1) ATE352315T1 (de)
AU (1) AU745183B2 (de)
BR (1) BR9812976A (de)
CA (1) CA2306642A1 (de)
DE (1) DE69836976T2 (de)
ES (1) ES2281936T3 (de)
NZ (1) NZ504035A (de)
WO (1) WO1999020303A1 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ504035A (en) 1997-10-20 2002-04-26 Bayer Ag Neospora vaccines comprising Neospora caninum antigens
EP0953641A3 (de) 1998-03-26 2002-03-13 Pfizer Products Inc. Für Neospora Proteine kodierende polynukleotid Moleküle
DE19958388A1 (de) * 1999-12-03 2001-06-07 Bayer Ag Triazinonverbindungen zur Behandlung von durch den Befall mit parasitischen Protozoen bedingten Krankheiten
AUPQ905600A0 (en) 2000-07-28 2000-08-24 Insearch Limited Parasites
ES2263317B2 (es) * 2003-12-04 2007-10-01 Universidad Complutense De Madrid Uso del gen ncsag4 para el diagnostico y prevencion de la neosporosis, y como marcador para el analisis de la patogenia.
ES2319242B1 (es) 2005-12-23 2009-12-01 Laboratorios Hipra, S.A. Aislado avirulento de neospora canimum y sus usos.
ES2326770B1 (es) * 2007-07-13 2010-07-26 Universidad Complutense De Madrid Uso de un nuevo aislado de neospora caninum para el desarrollo de pruebas de diagnostico y para la fabricacion de productos para el tratamiento y prevencion de la infenccion causada por neospora.
KR101144994B1 (ko) * 2008-05-06 2012-06-27 대한민국 소 네오스포라병 백신，이의 제조방법 및 이를 이용한 소네오스포라병 예방방법
WO2009156960A2 (en) * 2008-06-27 2009-12-30 Pfizer Inc. Novel adjuvant compositions
EP2485764A4 (de) 2009-10-09 2014-01-29 Childrens Medical Center Selektiv ausgeschalteter vollzellenimpfstoff
US10864260B2 (en) 2015-10-28 2020-12-15 Universidad Complutense De Madrid Neospora vaccine composition
PT3522871T (pt) * 2016-10-05 2022-01-05 Zoetis Services Llc Métodos de liofilização que fornecem protozoários estavelmente desidratados para utilização como vacinas vivas potentes

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4582798A (en) 1984-11-23 1986-04-15 Miles Laboratories, Inc. Preparation and use of enzyme-detergent extracted Streptococcus equi vaccine
US5583014A (en) 1990-07-03 1996-12-10 Bayer Corporation Preparation and use of enzyme-detergent extracted Streptococcus zoopidemicus vaccine
WO1994017813A1 (en) 1993-02-08 1994-08-18 Paravax, Inc. Defective sindbis virus vectors that express toxoplasma gondii p30 antigens
US5889166A (en) 1996-05-10 1999-03-30 The Regents Of The University Of California Recombinant neospora antigens and their uses
US5707617A (en) 1994-03-21 1998-01-13 The Regents Of The University Of California Bovine neospora isolates
CA2184132C (en) 1995-09-21 2011-03-15 Kristina J. Hennessy An adjuvanted vaccine which is substantially free of non-host albumin
US6476192B1 (en) * 1996-04-15 2002-11-05 Nicola C. Lally Recombinant antigens useful for the serodiagnosis of neosporosis
DK0841392T3 (da) * 1996-11-12 2004-11-22 Pfizer Svækket levende Neospora vaccine
BR9803232A (pt) * 1997-08-26 2000-01-11 Pfizer Prod Inc Vaicna de neospora.
NZ504035A (en) 1997-10-20 2002-04-26 Bayer Ag Neospora vaccines comprising Neospora caninum antigens
US6071737A (en) 1998-03-16 2000-06-06 The Regents Of The University Of California Equine Neospora isolate and its uses

Also Published As

Publication number Publication date
ATE352315T1 (de) 2007-02-15
EP1032416A1 (de) 2000-09-06
US7462359B2 (en) 2008-12-09
AU745183B2 (en) 2002-03-14
KR20010024245A (ko) 2001-03-26
WO1999020303A1 (en) 1999-04-29
DE69836976T2 (de) 2007-11-08
EP1032416B1 (de) 2007-01-24
US20020146436A1 (en) 2002-10-10
BR9812976A (pt) 2000-08-08
JP2001520205A (ja) 2001-10-30
ES2281936T3 (es) 2007-10-01
AU9693898A (en) 1999-05-10
NZ504035A (en) 2002-04-26
CA2306642A1 (en) 1999-04-29
US20050186227A1 (en) 2005-08-25

Similar Documents

Publication Publication Date Title
AU3438900A (en) Use of trehalose for stabilising a liquid vaccine
BR9605153B1 (pt) vacina de combinação, e, kit de vacinação.
DE69636487D1 (de) Zusammensetzungen zur Immuntherapie und Diagnose von Tuberculosis
ATE303160T1 (de) Impfstoff gegen prostatakrebs
DE69836976D1 (de) Neospora impstoff
EP2172551A3 (de) Verbindungen zur Immuntherapie und Diagnose von Tuberkulose und Verfahren zu deren Verwendung
CY1105364T1 (el) Μεθοδοι και συνθεσεις διαμορφωσης ανοσοποιησης
MY150893A (en) Recombinant mva virus expressing dengue virus antigens, and the use thereof in vaccines
BR9610679A (pt) Antígenos de leishmania para uso na terapia e disgnose da leishmaniose
EA199900069A1 (ru) Вакцинная композиция против малярии
EP0841392A3 (de) Attenuierter lebender Neospora Impfstoff
DE69838324D1 (de) Ph-sensitive liposomen und andere typen immunomodulatoren enthaltender gekapselter impfstoffe sowie herstellungs- und anwendungsverfahren dafür
GB9810084D0 (en) Proteins
AR027540A1 (es) Utilizacion de la proteina mic3 de toxoplasma gondii o de uno de sus derivados como agente inmunogeno o como antigeno de vacunacion
ATE353226T1 (de) Adjuvanszusammensetzung enthaltend fha oder ein fha-fragment in freier form
AR020022A1 (es) COMPOSICIONES DE ANTíGENOS DE ERYSILOPELOTHRIX RHUSIOPATHIAE, SU USO EN LA PREPARACIoN DE MEDICAMENTOS Y COMPOSICIONES DE VACUNAS.
MX9401384A (es) Uso de vacunas anti-helminticas en el control de la enfermedad por parasitos asociada con la perdidade la inmunidad natural.
WO2002000250A3 (en) Hiv-1 vaccines and screening methods therefor
NZ330913A (en) Antigens for preventing and reducing parasite infection and disease
WO2002024147A3 (en) Avian pneumovirus vaccine
CY1108543T1 (el) Εμβολια dna που κωδικοποιουν βοηθητικες πρωτεϊνες του hiv
ITMI940891A0 (it) Dispositivo di conservazione e di trasporto di organi umani sostanze medicinali vaccini e simili
FR2698271B1 (fr) Vaccin contre le virus de la leucémie bovine, nouveau peptide immunogène et kit de vaccination.
FI950253A (fi) Fimbria-antigeenejä, -vasta-aineita, -osoitusmenetelmiä ja -rokotteita
IT1295572B1 (it) Procedimento per il frazionamento di formaggi molli, in particolare stracchino, crescenza o simili e dispositivo per

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee